Further clinical relevance analysis revealed that methylation of FLRT2 is closely associated with tumor differentiation, lymphatic metastasis in CRC patients (Table 2), which strongly indicated that FLRT2 methylation is also involved in CRC progression. This evidence concerns the gene FLRT2 and colorectal carcinoma.